Advertisement
| bepotastine besilate ophthalmic solution 1.5: Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition , 2012-01-09 Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Obstructive Lung Diseases. The editors have built Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Obstructive Lung Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Obstructive Lung Diseases: Advances in Research and Treatment: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| bepotastine besilate ophthalmic solution 1.5: Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition , 2012-01-09 Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Conjunctival Diseases in a compact format. The editors have built Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Conjunctival Diseases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Conjunctival Diseases: Advances in Research and Treatment: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| bepotastine besilate ophthalmic solution 1.5: Ophthalmic Product Development Seshadri Neervannan, Uday B. Kompella, 2022-03-11 This is a comprehensive textbook addressing the unique aspects of drug development for ophthalmic use. Beginning with a perspective on anatomy and physiology of the eye, the book provides a critical appraisal of principles that underlie ocular drug product development. The coverage encompasses topical and intraocular formulations, small molecules and biologics (including protein and gene therapies), conventional formulations (including solutions, suspensions, and emulsions), novel formulations (including nanoparticles, microparticles, and hydrogels), devices, and specialty products. Critical elements such as pharmacokinetics, influence of formulation technologies and ingredients, as well as impact of disease conditions on products development are addressed. Products intended for both the front and the back of the eye are discussed with an eye towards future advances. @font-face {font-family:Cambria Math; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:Times New Roman,serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:Calibri,sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Times New Roman; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} |
| bepotastine besilate ophthalmic solution 1.5: Plumb's Veterinary Drug Handbook Donald C. Plumb, 2018-02-21 Plumb’s Veterinary Drug Handbook, Ninth Edition updates the most complete, detailed, and trusted source of drug information relevant to veterinary medicine. Provides a fully updated edition of the classic veterinary drug handbook, with carefully curated dosages per indication for clear guidance on selecting a dose Features 16 new drugs Offers an authoritative, complete reference for detailed information about animal medication Designed to be used every day in the fast-paced veterinary setting Includes dosages for a wide range of species, including dogs, cats, exotic animals, and farm animals |
| bepotastine besilate ophthalmic solution 1.5: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film Edward J Holland, Mark J Mannis, W. Barry Lee, 2013-05-17 Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today's best medical and surgical approaches. Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease. Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications. Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery. Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease. Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com. |
| bepotastine besilate ophthalmic solution 1.5: Side Effects of Drugs Annual Jeffrey K Aronson, 2014-03-04 The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading. - Provides a critical yearly survey of new data and trends - Special reviews in this Annual include, among other topics, epidemiology of the use of ecstasy, paracetamol and the risk of asthma, combination vaccines/multiple immunizations, interactions of herbal medicines with warfarin, and tyrosine kinase inhibitors |
| bepotastine besilate ophthalmic solution 1.5: The Medical Letter on Drugs and Therapeutics , 2010 |
| bepotastine besilate ophthalmic solution 1.5: Recent Developments in Anti-Inflammatory Therapy Parteek Prasher, Flavia Zacconi, Kamal Dua, Michael Rathbone, Jeffrey Withey, 2023-02-17 Advances in Anti-inflammatory Therapy explores the cutting-edge in anti-inflammation therapy in clear and concise language, with insights from academia and industry. Sections cover key regulatory pathways that mediate acute and chronic inflammation and disease onset. Further chapters are devoted to advanced anti-inflammatory pharmaceuticals, including chemical moieties, pharmacophores, APIs, natural products, herbal therapies, molecular nanomedicine and advanced drug delivery vectors. Systematically planned chapters and illustrations enable potential readers to gain essential insights on the most recent advancements in the field. Arranged with systematic chapters covering a broad range of inflammatory diseases, discussions on past, current and future therapeutics and advanced anti-inflammatory pharmaceuticals, this book will be useful to a wide range of researchers, especially medicinal chemists, drug design experts, and biological and translational researchers working in the field of inflammation. - Identifies recent developments and current trends in anti-inflammation therapy - Discusses advanced chemotherapeutics, SAR analysis of novel pharmacophores and natural products - Outlines the pathophysiology of inflammatory pathways in the pathogenesis of disease onset, including strategies to counter these intricacies - Contains a blend of editors from both academia and industry |
| bepotastine besilate ophthalmic solution 1.5: Stoklosa and Ansel's Pharmaceutical Calculations Shelly J. Stockton, 2021-03-22 The gold standard on pharmaceutical calculations, this widely acclaimed text covers the full range of calculations pharmacy students must learn for successful pharmacy practice, including dosing, compounding, metric conversions and more. Thoroughly reviewed by practitioners and educators and extensively revised and updated, this 16th edition maintains high standards for both academic and basic practice requirements while offering the most comprehensive and in-depth coverage of pharmacy calculations available. A consistent, step-by-step approach makes it easy to work through the problems and gain a greater understanding of the underlying concepts, and new online access to calculation problems makes this the most engaging edition yet. |
| bepotastine besilate ophthalmic solution 1.5: Pharmacology of Itch Alan Cowan, Gil Yosipovitch, 2015-04-10 Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios. |
| bepotastine besilate ophthalmic solution 1.5: Pharmaceutical Calculations Howard C. Ansel, 2012-10-26 Widely recognized as the leading calculations textbook, Ansel's Pharmaceutical Calculations is the most trusted resource for calculations support. Time-tested after thirteen editions, it is the most comprehensive and in-depth treatment of pharmacy calculations available. The book takes a step-by-step approach to calculations, making it easy for students to work through the problems and gain greater understanding of the underlying concepts. Its focus is on the fundamental principles and basic techniques involved in the application of the calculations needed for successful pharmacy practice. |
| bepotastine besilate ophthalmic solution 1.5: Plumb's Veterinary Drug Handbook James A. Budde, Dawn M. McCluskey, 2023-05-31 Plumb’sTM VETERINARY DRUG HANDBOOK Find drug dosages and other critical information for prescribing drugs to animals quickly and efficiently in this fully updated new edition of this must-have veterinary resource The Tenth Edition of Plumb’s® Veterinary Drug Handbook updates the most comprehensive, detailed, and trusted source of drug information relevant to veterinary medicine. Covering dosages, drug interactions, adverse effects, and contraindications, among other key drug details, this bestselling book is a must for practicing veterinarians and anyone requiring reliable information on the use of drugs in animals. Designed for ease of use, the book surveys an exhaustive list of drugs with applications for a wide variety of species, including dogs, cats, birds, small mammals, and farm animals. This edition includes updates to all 738 drug monographs and adds 30 new monographs, including 9 new insulin monographs, to its exhaustive coverage of drugs used in the care of animals. This new edition: Provides an extensively reviewed and updated version of the must-have veterinary drug reference Includes 30 new drug monographs, including 9 new insulin monographs Updates all 738 drug monographs, with robust citing of new information Covers a wide variety of species, including dogs, cats, birds, small mammals, and farm animals Presents detailed dosing information for an exhaustive list of drugs used in animals Plumb’s® exhaustive coverage of drugs relevant to the veterinary field makes this book an essential reference for veterinarians, veterinary technicians, veterinary pharmacologists, pharmacists with veterinary patients, and libraries that serve these groups. |
| bepotastine besilate ophthalmic solution 1.5: Nursing2018 Drug Handbook Lippincott, 2017-04-10 Fully updated with more than 4,300 clinical changes to nearly 3,500 generic, brand, and combination drugs New Drugs section featuring 29 new FDA-approved generics and their corresponding brand-name drugs New information on the National Cancer Institute's Common Terminology Criteria for Adverse Events classification system New appendices: Understanding biosimilar drugs Safe disposal of unused drugs: What patients need to know Prescription drug abuse: Identifying and treating toxicity Pregnancy-Lactation-Reproduction information highlighted in every monograph Easy-to-spot safety and clinical alerts: Black Box Warnings, Adjust-a-dose, Dialyzable drug, Overdose Signs & Symptoms, Look alike-Sound alike Drugs, IV Incompatibilities Nursing Considerations and Patient Teaching sections detailing the essential facts nurses need to know 32-page Photoguide featuring over 450 of the most commonly prescribed tablets and capsules Free access to Monthly Drug Updates and an Online Toolkit with hundreds of helpful tools and resources |
| bepotastine besilate ophthalmic solution 1.5: Frontiers in Clinical Drug Research - Anti-Allergy Agents Atta-ur-Rahman, 2018-07-11 Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field. |
| bepotastine besilate ophthalmic solution 1.5: Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders Uwe Pleyer, Jorge L. Alió, Talin Barisani-Asenbauer, Phuc Le Hoang, Narsing A. Rao, 2014-05-23 These guidelines, compiled by a panel of clinicians and scientists with a high level of expertise, aim to provide readers with the most up-to-date and comprehensive instructions on the treatment and prevention of ocular inflammation. All of the recommendations are explicitly linked to supporting evidence and graded according to the strength of that evidence and the editors have made every effort to ensure that chapters are of a consistently high methodological quality. The guidelines for each treatment include dose and the frequency and mode of delivery. Significant side-effects of treatment are identified and distinguished from those of the disease in question. Suggestions are presented for the prevention both of the disease itself and of the treatment-related complications. In addition, likely future directions in treatment and prevention are identified. These guidelines will be of great practical value for all clinicians and clinical scientists with an interest in the subject. |
| bepotastine besilate ophthalmic solution 1.5: Itch E. Carstens, Tasuku Akiyama, 2014-02-25 Advances in itch research have elucidated differences between itch and pain but have also blurred the distinction between them. There is a long debate about how somatic sensations including touch, pain, itch, and temperature sensitivity are encoded by the nervous system. Research suggests that each sensory modality is processed along a fixed, direct-line communication system from the skin to the brain. Itch: Mechanisms and Treatment presents a timely update on all aspects of itch research and the clinical treatment of itch that accompanies many dermatological conditions including psoriasis, neuropathic itch, cutaneous t-cells lymphomas, and systemic diseases such as kidney and liver disease and cancer. Composed of contributions from distinguished researchers around the world, the book explores topics such as: Neuropathic itch Peripheral neuronal mechanism of itch The role of PAR-2 in neuroimmune communication and itch Mrgprs as itch receptors The role of interleukin-31 and oncostatin M in itch and neuroimmune communication Spinal coding of itch and pain Spinal microcircuits and the regulation of itch Examining new findings on cellular and molecular mechanisms, the book is a compendium of the most current research on itch, its prevalence in society, and the problems associated with treatment. |
| bepotastine besilate ophthalmic solution 1.5: Allergic and Immunologic Diseases Christopher Chang, 2022-10-14 **Selected for Doody's Core Titles® 2024 in Allergy/Clinical Immunology** Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic Diseases is a valuable resource for researchers and others involved in the day-to-day practice of allergy and immunology, with specific information, protocols and algorithms to guide their thinking. The book provides practical information and an explanation of why and how we do things, while also addressing the limitations of testing and treatment. Other sections focus on scientific based practices and the known pathophysiology of allergic and immunologic diseases, along with mechanisms of action in various treatment modalities. This book is unique in that it explains the rationale behind everything we do in allergy and immunology, hence it offers readers specific information on procedures and how to order tests and treat allergic and immunologic diseases. - Contains useful information on allergic and immunologic diseases, from why we do things the way we do, to methodologies, interpretation of the results and management of diseases - Provides information that can be immediately downloadable for any specific procedure or treatment algorithm for immediate use - Evaluates scientific merit and evidence or lack thereof |
| bepotastine besilate ophthalmic solution 1.5: Pharmacologic Therapy of Ocular Disease Scott M. Whitcup, Dimitri T. Azar, 2017-06-05 There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function. |
| bepotastine besilate ophthalmic solution 1.5: The Southern African Guide to Topical Ophthalmic Drugs Dirk J Booysen and John L Booysen, 2022-05-13 The Southern African Guide to Topical Ophthalmic Drugs covers the mechanisms of action, indications for use and dosage of all the current diagnostic and therapeutic topical drugs used in ophthalmic practice in Southern Africa. The guide also includes clinical pearls and treatment guidelines for many ophthalmic conditions seen in clinical practice by general practitioners, dispensing pharmacists, optometrists and ophthalmologists. |
| bepotastine besilate ophthalmic solution 1.5: Nursing2017 Drug Handbook Lippincott, 2016-04-19 THE best-selling drug guide for nurses & other clinicians ...always dependable, always up to date! Look for these outstanding features Completely updated nursing-focused drug monographs featuring over 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format 49 brand-new FDA-approved drugs in this edition—with 36 new comprehensive drug monographs, alphabetized and conveniently grouped in a handy “new drugs” section Over 6,000 clinical updates—new dosages and indications, Black Box warnings, adverse reactions, nursing considerations, clinical alerts, and patient teaching information NEW “pregnancy-lactation-reproduction” heading and “dialyzable drug” logo in each drug monograph NEW appendices covering Antidiarrheals and OTC drugs Special attention to drug safety issues and concerns (U.S. and Canada) Over 455 Photoguide images of the most popular tablets and capsules Plus FREE companion Toolkit available online through NDHnow.com Monthly FDA updates on new drugs, indications, and warnings Pharmacology videos, audio pronunciation guide, and English-Spanish translator Equianalgesic dosing guidelines for opioid drugs Mechanisms and sites of action graphics for selected drugs NCLEX®-style questions, free CE tests, plus bonus discounts...and more! |
| bepotastine besilate ophthalmic solution 1.5: Conn's Current Therapy 2011 Edward T. Bope, Rick D. Kellerman, Robert E. Rakel, 2010-12-09 Conn’s Current Therapy 2011 is an easy-to-use, in-depth guide to the latest advances in therapeutics for common complaints and diagnoses. Drs. Edward T. Bope, Rick D. Kellerman, and Robert E. Rakel present the expertise and knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. With coverage of recent developments in travel medicine, sleep apnea, and immunization practices, as well as standardized diagnostic points and clinical recommendation tables, you’ll have access to the information you need. Deliver effective treatment after making correct diagnoses through discussions of important diagnostic criteria in each chapter. Get the best, most practical and accurate advice from acknowledged expert contributors. Apply best practices from around the world from coverage of management methods used by international experts. Stay current with recent developments in travel medicine, sleep apnea, immunization practices, and much more. Know the full range of treatment options through coverage of the latest information on recently-approved and soon-to-be-approved drugs. Tap into the guidance of experts for practical and accurate advice on diagnosis and management. Find the answers you need more easily with standardized Current Diagnostic Points and Current Therapy clinical recommendation tables. Accurately code for reimbursement using an up-to-date ICD-9 list of common diseases and codes. |
| bepotastine besilate ophthalmic solution 1.5: 2011 Nurse's Drug Handbook Jones Learning,, 2010-06-29 Jones and Bartlett Publishers 2011 Nurses Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference! It provides accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox; concise, consistently formatted drug entries organized alphabetically; no-nonsense writing style that speaks your language in terms you use everyday; index of all generic, trade, and alternate drug names for quick reference |
| bepotastine besilate ophthalmic solution 1.5: 2012 Nurse's Drug Handbook Jones and Bartlett Learning Staff, 2011-07-18 2012 Nurses Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. It provides: Accurate, timely facts on hundreds of drugs from abacavir sulfate to Zyvox Concise drug entries organized alphabetically No-nonsense writing style that speaks your language Quick reference index of all generic, trade, and alternate drug names |
| bepotastine besilate ophthalmic solution 1.5: 2020 Nurse's Drug Handbook Jones & Bartlett Learning,, 2019-11-08 Jones & Bartlett Learning 2020 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically. |
| bepotastine besilate ophthalmic solution 1.5: 2015 Nurse's Drug Handbook Jones & Bartlett Learning, 2015-01-14 Jones & Bartlett Learning 2015 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from abatacept to zonisamide. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically. |
| bepotastine besilate ophthalmic solution 1.5: Nursing2015 Drug Handbook Lippincott, 2014 As in previous editions, this handbook emphasizes nursing and safety aspects of drug administration without attempting to replace detailed pharmacology texts. Only the most essential information is included, and helpful grpahic symbols, logos, and highligting draw special attention to critical details that can't be overlooked.--page v. |
| bepotastine besilate ophthalmic solution 1.5: Litt's Drug Eruptions & Reactions Manual Neil Shear, 2011-01-15 Litt's Drug Eruptions and Reactions Manual (D.E.R.M.), is a guide to drug eruptions, adverse reactions and clinically relevant drug-drug interactions associated with over 1300 drugs. This simple, well-organised book systematically catalogues adverse reactions and cutaneous side-effects of drugs that are used to treat dozens of conditions.Internatio |
| bepotastine besilate ophthalmic solution 1.5: Nursing2013 Drug Handbook , 2012 Lists drug actions and interactions, describes drug therapy for children and the elderly, and provides details for the use of thousands of prescription drugs. |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2022 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, Kenneth R. McQuaid, 2021-09-03 The most popular annual guide of its kind—fully revised and updated to reflect all new clinical developments in every field of medicine For 60+ years, CURRENT Medical Diagnosis and Treatment―the flagship volume of the renowned Lange medical series―has been delivering the authoritative information students, residents, and clinicians need to build their medical knowledge, expertise, and confidence. Written by top experts in their fields, this unmatched guide is formatted in a way that enables you to find the answers you need quickly and easily. CURRENT Medical Diagnosis and Treatment 2022 focuses completely on solving practical bedside clinical issues without spending too much time on pathophysiology. It includes full review of all primary care topics, including gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, and urology. You’ll find everything you need to know about inpatient and outpatient care, along the with the most relevant diagnostic tools for day-to-day practice. Features: 320 images Hundreds of quick-access drug treatment tables, with indexed tradenames and updated drug prices Includes an annual review of advances in HIV treatment Includes Essentials of Diagnosis for most diseases/disorders Diagnostic/treatment algorithms present critical information in an at-a-glance format Up-to-date references provide peer-reviewed, evidence-based information Electronic only chapters available to all book customers, not just to CMDT online subscribers Expanded chapter content available online and in ebook for all chapter content |
| bepotastine besilate ophthalmic solution 1.5: 2023 Nurse's Drug Handbook Jones & Bartlett Learning,, 2022-11-18 Jones & Bartlett Learning 2023 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically. |
| bepotastine besilate ophthalmic solution 1.5: Ferri's Clinical Advisor 2023, E-Book Fred F. Ferri, 2022-06-21 For 25 years, Ferri's Clinical Advisor has provided immediate answers on the myriad medical diseases and disorders you're likely to encounter in a unique, easy-to-use format. A bestselling title year after year, this popular 5 books in 1 reference delivers vast amounts of information in a user-friendly manner. It is updated annually to provide current and clinically relevant answers on over 1,000 common medical conditions, including diseases and disorders, differential diagnoses, clinical algorithms, laboratory tests, and clinical practice guidelines?all carefully reviewed by experts in key clinical fields. Extensive algorithms, along with hundreds of high-quality photographs, illustrations, diagrams, and tables, ensure that you stay current with today's medical practice. - Contains significant updates throughout all 5 sections, covering all aspects of diagnosis and treatment. - Features 27 all-new topics including coronary artery dissection, perimandibular abscess, retinal vein occlusion, performance enhancing hormones, aphasia, hemorrhagic ovarian cyst, pelvic fracture, lung transplant, penile cancer and obsessive rumination syndrome, among others. - Includes useful appendices covering care of the transgender patient, palliative care, preoperative evaluation, nutrition, poison management, commonly used herbal products in integrated medicine, and much more. - Offers online access to Patient Teaching Guides in both English and Spanish. |
| bepotastine besilate ophthalmic solution 1.5: Nursing2019 Drug Handbook Lippincott, 2013-02-12 THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features Completely updated nursing-focused drug monographs featuring over 3,650 generic, brand-name, and combination drugs in an easy A-to-Z format 37 brand-new FDA-approved drugs in this edition, including 33 complete monographs—tabbed and conveniently grouped in a handy “new drugs” section for easy retrieval More than 8,000 clinical updates—new dosages and indications, Black Box warnings, adverse reactions, nursing considerations, clinical alerts, and patient teaching information NEW logos highlighting biosimilar drugs and drugs with genetic-related considerations NEW appendix—Ophthalmic drugs: Indications and dosages Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 462 commonly prescribed tablets and capsules Plus FREE companion Toolkit available online through NDHnow.com Monthly FDA updates featuring newly approved drugs, indications, and warnings Pharmacology videos, audio pronunciation guide, and English-Spanish translator Equianalgesic dosing guidelines for opioid drugs Mechanisms and sites of action graphics for selected drugs NCLEX®-style questions, free CE tests, plus bonus discounts...and more! |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2020 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, 2019-09-09 Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The #1 annual internal medicine guide that clinicians turn to first―extensively revised and updated A Doody's Core Title for 2020! CURRENT Medical Diagnosis & Treatment is the most comprehensive, reliable, and timely reference available to answer common questions that arise in everyday clinical practice. Written by clinicians renowned in their respective fields, this trusted classic offers expert advice on all aspects of outpatient and inpatient medical care. You’ll find authoritative, evidence-based coverage of more than 1,000 diseases and disorders including concise, yet thorough synopsis of diagnosis and treatment. Presented in full-color, this single source reference has been fully updated with the latest developments and breakthroughs in medicine, guidelines, references, drug prices, and more. This essential clinical companion features: A strong emphasis on the practical aspects of clinical diagnosis and patient management Detailed review of all internal medicine disciplines, including geriatrics, preventive medicine, and palliative care, plus gynecology and obstetrics, dermatology, ophthalmology, neurology, psychiatry, and more An annual update on HIV/AIDS and other new, emerging viral infections Specific information regarding disease prevention and prognosis Medication treatment tables, with indexed trade names and updated prices Key recent references on each topic with PMID numbers for quick online access Many full-color photographs, tables, figures and other illustrations. Here are some of the many updates and additions: Extensive updating of tables and images New FDA-approved medication for multiple sclerosis New summary of recommended FDA treatment regimens for hepatitis C U.S. Preventive Services Task Force recommendations for osteoporosis, prostate cancer, ovarian cancer, and cervical cancer Extensive update of immune modulation therapy and adjuvant treatments of breast cancer Targeted therapies for advanced non-small cell lung cancers Thoroughly revised chapter on viral and rickettsial infections, including recent measles, polio, and acute flaccid paralysis outbreaks, and on related immunizations Clarification of the appropriate role of opioids and buprenorphine formulations in chronic pain management Revised section on health care for sexual and gender minority patients Information on new biologic agents for asthma, and many other disorders |
| bepotastine besilate ophthalmic solution 1.5: Pediatric Allergy,E-Book Donald Y. M. Leung, Cezmi A Akdis, Leonard B. Bacharier, Charlotte Cunningham-Rundles, Scott H Sicherer, Hugh A. Sampson, 2020-10-19 With complete, concise coverage of prevention, indications, diagnosis, and treatment, Pediatric Allergy, 4th Edition, is your go-to resource for current, clinically-focused content in the rapidly changing field of allergies and immune-mediated diseases in children. This highly regarded reference fully covers immunology and origins of allergy, growth and development, pregnancy, infancy, and early, middle, and late childhood—all with a new, practical, clinical focus. You'll find authoritative coverage of the full range of allergies in pediatric patients, from asthma and other common conditions to rare or uncommon allergies, providing a one-stop resource for clinicians across specialties who care for children. - Focuses on the clinical application of science to the bedside, including clinical pearls discussing best practice approaches and guidelines. - Integrates the latest research on the origins of allergy in early life, including pregnancy, the neonate, and infants. - Includes new, evidence-based management guidelines for various diseases, including food allergy, atopic dermatitis, asthma and immunodeficiency. - Provides new content on the prevention of allergies; asthma, eczema, and food allergies in young children; and extensive current guidelines and new therapies. - Offers up-to-date information on key areas such as food challenges, skin testing, IgE diagnostic labs, immunotherapy, clinical immunology diagnostic testing, molecular diagnostics, and lung function testing. - Highlights current guidance from a new team of leading experts with 150 anatomic schematics, clinical photos, and algorithms—many new to this edition. - Covers gene therapy, stem-cell therapy, and a host of immunodeficiency diseases found in children with allergies. - Discusses targeted biologics for severe allergic diseases, defects of innate immunity, rheumatic diseases of childhood, and inflammatory disorders. - Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. |
| bepotastine besilate ophthalmic solution 1.5: 2014 Nurse's Drug Handbook Jones & Bartlett Learning,, 2013-06-11 Jones & Bartlett Learning 2014 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides: * Accurate, timely facts on hundreds of drugs from abatacept to zonisamide * Concise, consistently formatted drug entries organized alphabetically * No-nonsense writing style that speaks your language in terms you use everyday * Index of all generic, trade, and alternate drug names * Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule * Indications and dosages, as well as route, onset, peak, and duration information * Incompatibilities and contraindications * Interactions with drugs, food, and activities * Adverse reactions * Nursing considerations, including key patient-teaching points * Mechanism-of-action illustrations * Warnings and precautions New drug entries: * aclidinium bromide * anidulafungin * avanafil * icosapent ethyl * linaclotide * lorcserin * mifepristone * mirabegron * peginesatide * perampanel * teriflunomide * tofacitinib |
| bepotastine besilate ophthalmic solution 1.5: Nelson Textbook of Pediatrics, 2-Volume - E-Book Robert Kliegman, Joseph W. St. Geme III, 2024-03-29 **Selected for Doody's Core Titles® 2024 with Essential Purchase designation in Pediatrics**Covering every aspect of general pediatric practice, as well as details for many pediatric subspecialists, Nelson Textbook of Pediatrics, 22nd Edition, brings you fully up to date with everything from rapidly changing diagnostic and treatment protocols to new technologies to the wide range of biologic, psychologic, and social problems faced by children today. Edited and written by experts and prominent members of the pediatric medical community, this comprehensive two-volume reference covers both the science and art of pediatric practice. It remains the reference of choice among pediatricians, pediatric residents, and others involved in the care of young patients, delivering the information you need in a concise, easy-to-use format for everyday reference and study. - Features a user-friendly format with short chapters and subchapters that allow you to quickly find the information you need. - Includes more than 60 new chapters on topics covering the impact of social factors on children's health, the impact of genetic discoveries on understanding diagnosing and treating childhood diseases, updating of current evidenced based diagnostic and therapeutic approaches to childhood diseases, and more. - Offers new and expanded information on gene therapy; interferonopathies; reactive infectious mucocutaneous eruption (RIME); e-cigarette or vaping use-associated lung injury (EVALI); monkeypox; food protein-induced enterocolitis syndrome (FPIES); signaling pathway disorders; ciliopathies; very early onset inflammatory bowel disease; Epstein-Barr virus susceptibility disorders; marijuana smoke exposure; and much more. - Features hundreds of new figures and tables throughout for visual clarity and quick reference, real-time videos, and regular updates online, written exclusively for Nelson. - Provides fresh perspectives from two new associate editors: Abigail M. Schuh and Cara L. Mack, both of Medical College of Wisconsin. - Remains your indispensable source for definitive, evidence-based answers on every aspect of pediatric care. - Any additional digital ancillary content may publish up to 6 weeks following the publication date. |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2023 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, Kenneth R. McQuaid, 2022-09-09 A Doody's Core Title for 2023! The #1 annual internal medicine guide―extensively revised and updated The most popular annual guide of its kind, this updated edition of the flagship title of the LANGE medical book brand presents the most important diagnostic and treatment recommendations as well as the most useful new clinical developments in every field of adult medicine. For 60+ years, CURRENT Medical Diagnosis & Treatment has been delivering the authoritative information that students, residents, and clinicians need to build their medical knowledge, expertise, and confidence. Written by top experts in their fields, this unmatched guide enables you to find the answers you need quickly and easily. It provides: Coverage of more than 1,000 diseases and disorders Comprehensive approach to patient care, focusing on diagnostic tools for day-to-day practice Hundreds of drug treatment tables for quick access to indexed trade names and updated drug prices Diagnostic and treatment algorithms to present important information at a glance Carefully curated, updated references to provide peer-reviewed, evidence-based information, and PMID numbers for quick online access Annual update on dynamic viral infections, including SARS-CoV-2/COVID-19 and HIV/AIDS Hundreds of full-color photographs, illustrations, and algorithms |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2013 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, 2012-09-21 The #1 bestselling annual guide to internal medicine—now completely updated! Learn from the experts – and accelerate your clinical decision making Internationally acclaimed for its scholarship, conciseness, full-color presentation, and encyclopedic scope, CMDT puts the latest research where it belongs . . . into your practice. The new edition of this streamlined clinical companion delivers at-a-glance summaries of the signs, symptoms, epidemiology, etiology, and treatment options for more than 1,000 diseases and disorders. Practitioners in both the hospital and ambulatory settings rely on CMDT to keep up with new medical advances, prevention strategies, and cost-effective therapies. Here’s why CMDT is essential to clinical practice: Covers the fundamentals of clinical diagnosis and patient management in all fields of internal medicine A-to-Z survey of all primary care topics, including gynecology and obstetrics, dermatology, neurology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, and palliative care The only text with an annual update on the treatment of HIV infection and AIDS Easy-to-navigate design with numerous figures and tables Drug treatment tables, with indexed trade names and updated costs in each section Current references—with PubMed and PMID numbers “Essentials of Diagnosis” callouts for most diseases/disorders ICD-9 codes listed on inside covers NEW TO THIS EDITION: New chapter on Women’s Health Issues Extensively revised chapters: “Viral & Rickettsial Infections,” “Disorders Related to Environmental Factors,” and “Blood Disorders” Coverage of critical developments in anticoagulation and antiplatelet therapy, antihypertensive therapy, hematology, neurology, infectious disease, and cardiovascular medicine Important updates in oncology, including breast cancer treatment options, new lung cancer screening protocols, and cervical screening recommendations New risk assessment model for deep vein thrombosis (DVT) and DVT preventive therapies following hip or knee replacement Recent CDC guidelines on adult and adolescent immunizations and the treatment of sexually transmitted infections Overview of new medications, including ivacaftor, eltrombopag, romiplostim, and eculizumab Extensive revision of the section on rhabdomyolysis New section on peripheral artery aneurysms |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2024 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, Kenneth R. McQuaid, Monica Gandhi, 2023-09-11 The #1 annually updated general medical text—presents the most important diagnostic and treatment recommendations as well as the most useful new clinical developments in every field of adult medicine. For more than six decades, CURRENT Medical Diagnosis & Treatment has been delivering the authoritative information students, residents, and clinicians need to build their medical knowledge, expertise, and confidence. Written by top experts in their fields, this unmatched guide is formatted in a way that enables readers to find the answers they need quickly and easily. CURRENT Medical Diagnosis & Treatment 2024 reflects the latest developments in medicine, guidelines, references, and more. You’ll find authoritative, evidence-based coverage of more than 1,000 diseases and disorders along with a concise, yet thorough synopsis of diagnosis and treatment. This trusted classic covers all aspects of outpatient and inpatient care and includes discussion of new developments and breakthroughs in medicine. CURRENT Medical Diagnosis & Treatment 2024 features: A comprehensive approach to patient care, focusing on the diagnostic tools relevant to daily practice Coverage of more than 1,000 diseases and disorders Hundreds of drug treatment tables for quick access to indexed trade names Annual updates to topics in all chapters in a consistent format, drugs, tables, and images Year in Review highlighting the many topics with significant clinical changes over the last year Essentials of Diagnosis for most diseases/disorders Diagnostic and treatment algorithms present complex information in an at-a-glance style Hundreds of full-color photos and illustrations New to this edition: Latest USPSFT recommendations for cardiovascular risk prevention Significant new opioid prescribing guidelines from the CDC Clarification on the distinction between uncontrolled hypertensive and hypertension emergency Latest classification of lymphomas released by the WHO Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy Current treatment guidelines and medications for H pylori infection Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions |
| bepotastine besilate ophthalmic solution 1.5: CURRENT Medical Diagnosis and Treatment 2021 Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow, 2020-09-09 Now includes a “Year in Review” highlighting over 180 recent medical advances since the last edition! Doody's Core Titles for 2021! For 60 years, CURRENT Medical Diagnosis and Treatment—the flagship volume of the renowned Lange medical series—has been delivering the authoritative information students, residents, and clinicians need to build their medical knowledge, expertise, and confidence. Covering the latest clinical developments in all facets of medicine and fully focused on bedside clinical issues, this new edition provides completely the latest guidelines, reference, drug prices, approved drugs, and evidence-based coverage of more than 1,000 diseases and disorders—all formatted to enable you to find the answers you need quickly and effortlessly. This landmark guide covers inpatient and outpatient care, focusing on the diagnostic tools relevant to daily practice, and reviews all primary care topics, including gynecology/obstetrics, dermatology, ophthalmology, geriatrics, preventive medicine, psychiatry, and neurology. Now includes a “year in review” feature highlighting what’s new in CMDT! Includes essentials of diagnosis for most diseases/disorders Hundreds of quick-access drug treatment tables with indexed trade names Diagnostic and treatment algorithms present important information in an at-a-glance style Up-to-date references provide peer-reviewed, evidence-based information Seven bonus chapters available online to all book purchasers, featuring expanded content and annual review of advances in HIV treatment and critical information on emerging viral infections |
Bepotastine: Indications, Side Effects, Warnings - Drugs.com
Bepotastine. Generic name: Bepotastine [ be-poe-TAS-teen ] Brand name: Bepreve Drug class: Ophthalmic antihistamines and decongestants. Uses; Before taking; Warnings; Dosage; Side …
Bepotastine - Wikipedia
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. [2] It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000, and January 2002, …
Bepreve (Bepotastine): Uses, Side Effects, Dosage & More - GoodRx
Apr 4, 2025 · Bepotastine (Bepreve) is an allergy eye drop for people over the age of 2. It's an antihistamine medication that helps with itchy eyes from allergies. The typical dosing is to put 1 …
Bepotastine (Bepreve) - Uses, Side Effects, and More
Dec 4, 2024 · Overview: Bepotastine is an eye drop used to treat itchy eyes caused by allergies. The most common side effects are eye irritation, headache, infection in the nose or throat, or …
Bepotastine besilate (ophthalmic route) - Mayo Clinic
Feb 1, 2025 · Bepotastine besilate eye drops is used to treat itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the effects of certain …
Bepotastine: Uses, Interactions, Mechanism of Action ...
Oct 21, 2007 · Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. It belongs to the second-generation piperidine chemical class. It is a mast cell …
Bepreve (bepotastine) dosing, indications, interactions ...
Medscape - Indication-specific dosing for Bepreve (bepotastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …
Bepotastine: Indications, Side Effects, Warnings - Drugs.com
Bepotastine. Generic name: Bepotastine [ be-poe-TAS-teen ] Brand name: Bepreve Drug class: Ophthalmic antihistamines and decongestants. Uses; Before taking; Warnings; Dosage; Side …
Bepotastine - Wikipedia
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. [2] It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000, and January 2002, …
Bepreve (Bepotastine): Uses, Side Effects, Dosage & More - GoodRx
Apr 4, 2025 · Bepotastine (Bepreve) is an allergy eye drop for people over the age of 2. It's an antihistamine medication that helps with itchy eyes from allergies. The typical dosing is to put …
Bepotastine (Bepreve) - Uses, Side Effects, and More
Dec 4, 2024 · Overview: Bepotastine is an eye drop used to treat itchy eyes caused by allergies. The most common side effects are eye irritation, headache, infection in the nose or throat, or …
Bepotastine besilate (ophthalmic route) - Mayo Clinic
Feb 1, 2025 · Bepotastine besilate eye drops is used to treat itching of the eye caused by a condition known as allergic conjunctivitis. It works by preventing the effects of certain …
Bepotastine: Uses, Interactions, Mechanism of Action ...
Oct 21, 2007 · Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. It belongs to the second-generation piperidine chemical class. It is a mast cell …
Bepreve (bepotastine) dosing, indications, interactions ...
Medscape - Indication-specific dosing for Bepreve (bepotastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …
